Invesco Exchange-Traded Self-Indexed Fund Trust has recently submitted its NPORT-P report, providing an update on its financial status as of August 31, 2026. The filing, made on October 30, 2026, reveals that the trust holds total assets of approximately $2.5 million and net assets of about $2.5 million. This report is crucial as it underscores the company's commitment to transparency in its investment strategies.
The Invesco Exchange-Traded Self-Indexed Fund Trust operates under the investment category and focuses on managing exchange-traded funds (ETFs). The firm is based in Downers Grove, Illinois, and has undergone name changes in the past, previously known as PowerShares Exchange-Traded Self-Indexed Fund Trust. This latest filing is part of a series of submissions made on the same day, indicating a proactive approach to regulatory compliance.
According to the filing, the total liabilities reported are minimal, standing at just over $110. This indicates a strong financial position for the trust, with a net asset value that significantly outweighs its liabilities. The filing also highlights that the trust's investment strategy includes U.S. Treasury Notes and Bonds, which are considered secure investments.
The impact of this filing extends beyond just the Invesco trust. It highlights the ongoing trend within the investment management industry towards greater transparency and regulatory compliance. Investors and stakeholders are increasingly looking for detailed insights into fund performance and asset management strategies. This trend is particularly relevant in the ETF market, where competition is fierce and investors demand clarity.
Looking ahead, the filing does not specify what actions will follow this report, but it serves as a critical update for investors tracking the fund's performance and strategic direction. As the investment landscape continues to evolve, Invesco's commitment to transparency may set a benchmark for other firms in the industry.
Read Next
Jefferies CEO Handler Reports Stock Transactions in SEC Filing
Brophy Michael Burkes sells 3,084 shares of Natera stock
Glenbrook Capital Management Boosts Stake in SenesTech
OS Therapies grants stock options to Chief Medical Officer
Belite Bio CEO Lin Yu-Hsin Vests 5,000 Shares
Chen Wan-Shan Reports Share Transaction for Belite Bio






